Literature DB >> 4829221

Maintenance of tonic vasomotor activity by alpha and beta adrenergic mechanisms in medullary cardiovascular centers.

A Ito, S M Schanberg.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4829221

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  5 in total

1.  Effect of the norepinephrine receptor stimulating agent "clonidine" on the turnover of 5-hydroxytryptamine in some areas of the rat brain.

Authors:  L Rochette; J Bralet
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

2.  Long term treatment of moderate hypertension with penbutolol (Hoe 893d). II. Effect on the response of plasma catecholamines and plasma renin activity to insulin-induced hypoglycemia.

Authors:  B G Hansson
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

3.  beta-Adrenoceptor blocking drugs and isoprenaline: central effects on cardiovascular parameters.

Authors:  Y Cohen; A Lindenbaum; M Midol-Monnet; D Porquet; J Wepierre
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

Review 4.  6-hydroxydopamine destruction of central adrenergic neurones prevents or reverses developing DOCA-salt hypertension in rats.

Authors:  F Lamprecht; J S Richardson; R B Williams; I J Kopin
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

5.  A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.

Authors:  P Ernsberger; M A Haxhiu; L M Graff; L A Collins; I Dreshaj; D L Grove; M E Graves; S G Schäfer; M O Christen
Journal:  Cardiovasc Drugs Ther       Date:  1994-03       Impact factor: 3.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.